These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30419293)

  • 21. Comparative pharmacokinetics of spectinamide 1599 after subcutaneous and intrapulmonary aerosol administration in mice.
    Rathi C; Lukka PB; Wagh S; Lee RE; Lenaerts AJ; Braunstein M; Hickey A; Gonzalez-Juarrero M; Meibohm B
    Tuberculosis (Edinb); 2019 Jan; 114():119-122. PubMed ID: 30711150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A proposal of a pharmacokinetic/pharmacodynamic (PK/PD) index map for selecting an optimal PK/PD index from conventional indices (AUC/MIC, Cmax/MIC, and TAM) for antibiotics.
    Kitamura Y; Yoshida K; Kusama M; Sugiyama Y
    Drug Metab Pharmacokinet; 2014; 29(6):455-62. PubMed ID: 25008846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spectinamides: a challenge, a proof, and a suggestion.
    Viveiros M; Pieroni M
    Trends Microbiol; 2014 Apr; 22(4):170-1. PubMed ID: 24636244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mycobacterium tuberculosis gyrase inhibitors as a new class of antitubercular drugs.
    Blanco D; Perez-Herran E; Cacho M; Ballell L; Castro J; González Del Río R; Lavandera JL; Remuiñán MJ; Richards C; Rullas J; Vázquez-Muñiz MJ; Woldu E; Zapatero-González MC; Angulo-Barturen I; Mendoza A; Barros D
    Antimicrob Agents Chemother; 2015 Apr; 59(4):1868-75. PubMed ID: 25583730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of novel 5-(ethyl or hydroxymethyl) analogs of 2'-'up' fluoro (or hydroxyl) pyrimidine nucleosides as a new class of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium avium inhibitors.
    Shakya N; Srivastav NC; Bhavanam S; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R
    Bioorg Med Chem; 2012 Jul; 20(13):4088-97. PubMed ID: 22664188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-mycobacterial activity of 1,3-diaryltriazenes.
    Cappoen D; Vajs J; Uythethofken C; Virag A; Mathys V; Kočevar M; Verschaeve L; Gazvoda M; Polanc S; Huygen K; Košmrlj J
    Eur J Med Chem; 2014 Apr; 77():193-203. PubMed ID: 24631899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of the Rv2333c efflux pump (the Stp protein) from Mycobacterium tuberculosis to intrinsic antibiotic resistance in Mycobacterium bovis BCG.
    Ramón-García S; Martín C; De Rossi E; Aínsa JA
    J Antimicrob Chemother; 2007 Mar; 59(3):544-7. PubMed ID: 17242035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Moxifloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis: evaluation of in vitro and pharmacodynamic indices that best predict in vivo efficacy.
    Shandil RK; Jayaram R; Kaur P; Gaonkar S; Suresh BL; Mahesh BN; Jayashree R; Nandi V; Bharath S; Balasubramanian V
    Antimicrob Agents Chemother; 2007 Feb; 51(2):576-82. PubMed ID: 17145798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meropenem-clavulanate has high in vitro activity against multidrug-resistant Mycobacterium tuberculosis.
    Davies Forsman L; Giske CG; Bruchfeld J; Schön T; Juréen P; Ängeby K
    Int J Mycobacteriol; 2015 Mar; 4 Suppl 1():80-1. PubMed ID: 27128620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploration of optimal dosing regimens of vancomycin in patients infected with methicillin-resistant Staphylococcus aureus by modeling and simulation.
    Lim HS; Chong YP; Noh YH; Jung JA; Kim YS
    J Clin Pharm Ther; 2014 Apr; 39(2):196-203. PubMed ID: 24428720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis and antitubercular potency of 4-hydroxyquinolin-2(1H)-ones.
    de Macedo MB; Kimmel R; Urankar D; Gazvoda M; Peixoto A; Cools F; Torfs E; Verschaeve L; Lima ES; Lyčka A; Milićević D; Klásek A; Cos P; Kafka S; Košmrlj J; Cappoen D
    Eur J Med Chem; 2017 Sep; 138():491-500. PubMed ID: 28689097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting human macrophages for enhanced killing of intracellular XDR-TB and MDR-TB.
    Martins M; Viveiros M; Couto I; Amaral L
    Int J Tuberc Lung Dis; 2009 May; 13(5):569-73. PubMed ID: 19383188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and antitubercular activity of new 1,3,4-oxadiazoles bearing pyridyl and thiazolyl scaffolds.
    Dhumal ST; Deshmukh AR; Bhosle MR; Khedkar VM; Nawale LU; Sarkar D; Mane RA
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3646-51. PubMed ID: 27301367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Studies of the resistance of mycobacteria].
    Savov N
    Vet Med Nauki; 1973; 10(2):39-49. PubMed ID: 4213759
    [No Abstract]   [Full Text] [Related]  

  • 37. Importance of differential identification of Mycobacterium tuberculosis strains for understanding differences in their prevalence, treatment efficacy, and vaccine development.
    Chae H; Shin SJ
    J Microbiol; 2018 May; 56(5):300-311. PubMed ID: 29721826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Azole-antifungal binding to a novel cytochrome P450 from Mycobacterium tuberculosis: implications for treatment of tuberculosis.
    Guardiola-Diaz HM; Foster LA; Mushrush D; Vaz AD
    Biochem Pharmacol; 2001 Jun; 61(12):1463-70. PubMed ID: 11377375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benzimidazole-based compounds kill Mycobacterium tuberculosis.
    Gong Y; Somersan Karakaya S; Guo X; Zheng P; Gold B; Ma Y; Little D; Roberts J; Warrier T; Jiang X; Pingle M; Nathan CF; Liu G
    Eur J Med Chem; 2014 Mar; 75():336-53. PubMed ID: 24556148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antitubercular effect of capreomycin in vitro].
    Janowiec M
    Gruzlica; 1969 Jul; 37(7):629-35. PubMed ID: 4981783
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.